Szostak Nobel prize in medicine

Jack W. Szostak, a geneticist at Harvard Medical School, is one of three co-winners of the 2009 prize.

Jack Szostak

Jack Szostak | Courtesy of Massachusetts General Hospital

Professor of genetics Jack W. Szostak has won the Nobel Prize in Physiology or Medicine with Elizabeth H. Blackburn (University of California, San Francisco) and Carol W. Greider (Johns Hopkins School of Medicine). The three scientists were recognized for their work on how chromosomes are protected by telomeres and the enzyme telomerase. Szostak's home page at Harvard Medical School details his recent work on the synthesis of life on earth: "the related challenges of understanding the origin of life on the early earth, and constructing synthetic cellular life in the laboratory." His lab home page is here; he is also a Howard Hughes Medical Institute investigator, and  has a biographical page there, emphasizing his current work on the origins of life and the re-creation of the first steps in biological synthesis. Harvard's Origins of Life Initiative is described here; Szostak is one of the affiliated faculty members.

According to the Nobel press release, the trio have solved a critical part of a fundamental problem in biology: "how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes--the telomeres--and in an enzyme that forms them – telomerase."


The explanation continues:

The long, thread-like DNA molecules that carry our genes are packed into chromosomes, the telomeres being the caps on their ends. Elizabeth Blackburn and Jack Szostak discovered that a unique DNA sequence in the telomeres protects the chromosomes from degradation. Carol Greider and Elizabeth Blackburn identified telomerase, the enzyme that makes telomere DNA. These discoveries explained how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase.


If the telomeres are shortened, cells age. Conversely, if telomerase activity is high, telomere length is maintained, and cellular senescence is delayed. This is the case in cancer cells, which can be considered to have eternal life. Certain inherited diseases, in contrast, are characterized by a defective telomerase, resulting in damaged cells. The award of the Nobel Prize recognizes the discovery of a fundamental mechanism in the cell, a discovery that has stimulated the development of new therapeutic strategies.

 

Related topics

You might also like

The University will compensate families of those whose remains were sold and establish a scholarship to honor anatomical donors.

After a final round of layoffs, University leaders say 165 staff jobs were eliminated across the division.

Long-discussed reorganization includes layoffs and the end of the Dudley Community.

Most popular

Social Media Use and Adult Depression

A survey reveals suprising links between social media use and depression in adults.

The Franklin Stove—A Historical Climate Change Adaptation

Historian Joyce E. Chaplin reinterprets an early era of invention, industrialization, and climate challenge

In 2004, a frenzy spread across Harvard Yard in days. Four billion users later, we are only just catching up.

Explore More From Current Issue

A glowing bulb shape surrounded by colorful, swirling energy lines against a blue background.

Harvard researchers achieve medical breakthroughs in cancer therapy and infection control.

Decorative wrought iron gate framed by leafy branches, captured in sepia tones.

Former Indiana University president Thomas Ehrlich looks back on curriculum, co-education, and other major trends.

Three actors perform on stage, with one actor interacting closely with another, set against abstract backgrounds.

The play Spare Parts is a contemporary fable about the quest to live forever.